Sign inJoin waitlistJoin the waitlist

Rebecca Shatsky

Professor of Medicine · University of California (San Diego) Medical Center

Credentials: · · · · ·

History

University of California (San Diego) Medical Center
Present

Hematology and Medical Oncology
2014–2017
Internal Medicine
University of California-Los Angeles
2011–2014
Keck Sch of Med of the Univ of Southern Calif
2007–2011

Research

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 914 citations
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively…
JAMA Oncology · 2020 · 610 citations
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 454 citations

Angela DeMichele
15 papers
Laura Esserman
15 papers
Claudine Isaacs
14 papers
Hope Rugo
14 papers
Douglas Yee
13 papers
Jo Chien
10 papers
William Symmans
10 papers
Anne Wallace
9 papers
Judy Boughey
9 papers
Rita Nanda
8 papers
Amy Clark
7 papers
Kevin Kalinsky
7 papers

Clinical trials

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Aminex Therapeutics, Inc.
2026–2028
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
Site PI · Recruiting · Phase 1
Mabwell (Shanghai) Bioscience Co., Ltd.
2025–2028
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Site PI · Recruiting · Phase 1, Phase 2
A2 Biotherapeutics Inc.
2025–2030
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Site PI · Recruiting · Phase 1
NiKang Therapeutics, Inc.
2025–2027